Skip to main content
. 2020 Jul 23;8:851. doi: 10.3389/fbioe.2020.00851

TABLE 1.

Bioprocess features selected by each surrogate modeling technique from Feature Set 1 (X = selected).

Feature FS1-RF FS1-GPR FS1-MARS
Average DO concentration dd0 X
Average DO concentration gradient d0 X X
Average DO concentration gradient dd2 X
Average DO concentration gradient dd6 X
Average DO concentration gradient dd7 X
d0 average pH gradient X
dd0 average pH gradient X
dd0 average acceleration of cell density normalized DO gradient X
dd0–dd1 cell density gradient X X
dd1 aggregate size X
dd1 cell density X
dd2 average pH X
dd7 average pH X
dd3 aggregate size X
dd3 average acceleration of DO gradient X
dd3 average pH gradient X
dd3 average acceleration of cell density normalized DO gradient X
dd5 average pH gradient
dd5–dd7 aggregate size gradient X
dd5–dd7 cell density gradient X
dd7 cell density X X
Cell density normalized DO concentration dd2 X
Cell density normalized DO concentration dd3 X X
Cell density normalized DO concentration dd7 X
Average cell density normalized DO concentration gradient dd2 X X
Average cell density normalized DO concentration gradient dd5 X
Average cell density normalized DO concentration gradient dd7 X
IWP2 treatment time [h] X
Preculture time [h] X